Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

MEF2 signaling and human diseases.

Chen X, Gao B, Ponnusamy M, Lin Z, Liu J.

Oncotarget. 2017 Dec 4;8(67):112152-112165. doi: 10.18632/oncotarget.22899. eCollection 2017 Dec 19. Review.

2.

MEF2C Interacts With c-FOS in PTH-Stimulated Mmp13 Gene Expression in Osteoblastic Cells.

Nakatani T, Partridge NC.

Endocrinology. 2017 Nov 1;158(11):3778-3791. doi: 10.1210/en.2017-00159.

PMID:
28973134
3.

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers.

Tobin SW, Hashemi S, Dadson K, Turdi S, Ebrahimian K, Zhao J, Sweeney G, Grigull J, McDermott JC.

Sci Rep. 2017 Jun 30;7(1):4476. doi: 10.1038/s41598-017-04762-x.

4.

PKA-mediated phosphorylation of Dexras1 suppresses iron trafficking by inhibiting S-nitrosylation.

Chen Y, Mathias L, Falero-Perez JM, Kim SF.

FEBS Lett. 2015 Oct 7;589(20 Pt B):3212-9. doi: 10.1016/j.febslet.2015.08.041. Epub 2015 Sep 7.

5.

β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells.

Salto R, Vílchez JD, Girón MD, Cabrera E, Campos N, Manzano M, Rueda R, López-Pedrosa JM.

PLoS One. 2015 Aug 12;10(8):e0135614. doi: 10.1371/journal.pone.0135614. eCollection 2015.

6.

Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications.

Liu X, Huang S, Wang X, Tang B, Li W, Mao Z.

Neurosci Bull. 2015 Aug;31(4):407-15. doi: 10.1007/s12264-015-1542-8. Epub 2015 Jul 23. Review.

7.

mAKAP-a master scaffold for cardiac remodeling.

Passariello CL, Li J, Dodge-Kafka K, Kapiloff MS.

J Cardiovasc Pharmacol. 2015 Mar;65(3):218-25. doi: 10.1097/FJC.0000000000000206. Review.

8.

Differential effects of binge methamphetamine injections on the mRNA expression of histone deacetylases (HDACs) in the rat striatum.

Omonijo O, Wongprayoon P, Ladenheim B, McCoy MT, Govitrapong P, Jayanthi S, Cadet JL.

Neurotoxicology. 2014 Dec;45:178-84. doi: 10.1016/j.neuro.2014.10.008. Epub 2014 Oct 27.

9.

A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.

Cassar M, Issa AR, Riemensperger T, Petitgas C, Rival T, Coulom H, Iché-Torres M, Han KA, Birman S.

Hum Mol Genet. 2015 Jan 1;24(1):197-212. doi: 10.1093/hmg/ddu430. Epub 2014 Aug 25.

10.

Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.

Zhang L, Sun Y, Fei M, Tan C, Wu J, Zheng J, Tang J, Sun W, Lv Z, Bao J, Xu Q, Yu H.

Autophagy. 2014 Jun;10(6):1015-35. doi: 10.4161/auto.28477.

11.

Natural variation in the histone demethylase, KDM4C, influences expression levels of specific genes including those that affect cell growth.

Gregory BL, Cheung VG.

Genome Res. 2014 Jan;24(1):52-63. doi: 10.1101/gr.156141.113. Epub 2013 Nov 27.

12.

MEF2 is an in vivo immune-metabolic switch.

Clark RI, Tan SW, Péan CB, Roostalu U, Vivancos V, Bronda K, Pilátová M, Fu J, Walker DW, Berdeaux R, Geissmann F, Dionne MS.

Cell. 2013 Oct 10;155(2):435-47. doi: 10.1016/j.cell.2013.09.007. Epub 2013 Sep 26.

13.

Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Mount MP, Zhang Y, Amini M, Callaghan S, Kulczycki J, Mao Z, Slack RS, Anisman H, Park DS.

J Biol Chem. 2013 May 17;288(20):14362-71. doi: 10.1074/jbc.M112.439216. Epub 2013 Mar 27.

14.

Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.

Yao L, Li W, She H, Dou J, Jia L, He Y, Yang Q, Zhu J, Cápiro NL, Walker DI, Pennell KD, Pang Y, Liu Y, Han Y, Mao Z.

J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13.

15.

Neurotoxin-induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response.

She H, Yang Q, Mao Z.

J Neurochem. 2012 Sep;122(6):1203-10. doi: 10.1111/j.1471-4159.2012.07860.x. Epub 2012 Aug 3.

16.

Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson's Disease.

Yin Y, She H, Li W, Yang Q, Guo S, Mao Z.

Front Physiol. 2012 May 29;3:171. doi: 10.3389/fphys.2012.00171. eCollection 2012.

17.

Nurr1 protein is required for N-methyl-D-aspartic acid (NMDA) receptor-mediated neuronal survival.

Barneda-Zahonero B, Servitja JM, Badiola N, Miñano-Molina AJ, Fadó R, Saura CA, Rodríguez-Alvarez J.

J Biol Chem. 2012 Mar 30;287(14):11351-62. doi: 10.1074/jbc.M111.272427. Epub 2012 Jan 31.

18.

Calpain-mediated degradation of myocyte enhancer factor 2D contributes to excitotoxicity by activation of extrasynaptic N-methyl-D-aspartate receptors.

Wei G, Yin Y, Li W, Bito H, She H, Mao Z.

J Biol Chem. 2012 Feb 17;287(8):5797-805. doi: 10.1074/jbc.M111.260109. Epub 2012 Jan 3.

19.

Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.

She H, Yang Q, Shepherd K, Smith Y, Miller G, Testa C, Mao Z.

J Clin Invest. 2011 Mar;121(3):930-40. doi: 10.1172/JCI43871.

20.

Differential roles of Epac in regulating cell death in neuronal and myocardial cells.

Suzuki S, Yokoyama U, Abe T, Kiyonari H, Yamashita N, Kato Y, Kurotani R, Sato M, Okumura S, Ishikawa Y.

J Biol Chem. 2010 Jul 30;285(31):24248-59. doi: 10.1074/jbc.M109.094581. Epub 2010 Jun 1.

Supplemental Content

Support Center